The online retailer sells supplements making grandiose health claims and at least one medical device without government oversight.
Source:: Personal Finance
Morgan to voters: Keep PED users out of HOF …read more
By Walter Bianchi MAR DEL PLATA, Argentina (Reuters) – Rescuers searching for an Argentine navy submarine that went missing in the South Atlantic nearly a week ago with 44 crew aboard were expected to be able to pick up the pace on Tuesday as fierce weather abated. Storms and high winds have limited the search for the ARA San Juan in the past several days. Luckily, from today onwards the intensity of the wind and the height of the sea will begin to fall,” navy spokesman Enrique Balbi told reporters.
Former NFL WR Glenn, 43, dies in car accident …read more
By John Miller ZURICH (Reuters) – Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines. Along with Roche’s multiple sclerosis medicine Ocrevus, the drugs are pillars of Chief Executive Severin Schwan’s plan to offset the patent expiry of top-sellers Rituxan, Avastin and Herceptin which account for $20 billion in annual sales. Roche said Tecentriq had cut the risk of lung cancer worsening when mixed with other treatments, while hemophilia agent Hemlibra had reduced bleeds in a new group of patients.